Evidence map›Paper›PMID 38694784›Full record

ReviewFrontiers in oncology2024

A new era in the management of spinal metastasis.

Tadatsugu Morimoto, Yu Toda, Michiyuki Hakozaki, Permsak Paholpak, Kazuyuki Watanabe, Kinshi Kato, Masatsugu Tsukamoto, Hirohito Hirata, Yoichi Kaneuchi, Yasunori Tome and 7 more

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
8.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Trends and postoperative complications of spinal metastasis surgery in Thailand between 2015 and 2024: a nationwide retrospective cohort study.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2026
    Article
  5. Article
  6. Diagnostic errors in spinal metastases: a systematic review of contributing clinical and systemic factors.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2026
    Review
  7. Radiomics in spinal research: a narrative review.Frontiers in bioengineering and biotechnology · 2026
    Review
  8. Multiple myeloma complicated with spinal infiltration: a case report.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 2 countries.

Tadatsugu MorimotoDepartment of Orthopedic Surgery, Faculty of Medicine, Saga University, Saga, Japan.
Yu TodaDepartment of Orthopedic Surgery, Faculty of Medicine, Saga University, Saga, Japan.
Michiyuki HakozakiDepartment of Orthopaedic Surgery, Fukushima Medical University School of Medicine, Fukushima, Japan.
Permsak PaholpakDepartment of Orthopedics, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
Kazuyuki WatanabeDepartment of Orthopaedic Surgery, Fukushima Medical University School of Medicine, Fukushima, Japan.
Kinshi KatoDepartment of Orthopaedic Surgery, Fukushima Medical University School of Medicine, Fukushima, Japan.
Masatsugu TsukamotoDepartment of Orthopedic Surgery, Faculty of Medicine, Saga University, Saga, Japan.
Hirohito HirataDepartment of Orthopedic Surgery, Faculty of Medicine, Saga University, Saga, Japan.
Yoichi KaneuchiDepartment of Orthopaedic Surgery, Fukushima Medical University School of Medicine, Fukushima, Japan.
Yasunori TomeDepartment of Orthopedic Surgery, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan.
Satomi NagamineDepartment of Orthopedic Surgery, Faculty of Medicine, Saga University, Saga, Japan.
Kotaro NishidaDepartment of Orthopedic Surgery, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan.
Hiroo KatsuyaDivision of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, Japan.
Yoshihiro MatsumotoDepartment of Orthopaedic Surgery, Fukushima Medical University School of Medicine, Fukushima, Japan.
Koji OtaniDepartment of Orthopaedic Surgery, Fukushima Medical University School of Medicine, Fukushima, Japan.
Masaaki MawatariDepartment of Orthopedic Surgery, Faculty of Medicine, Saga University, Saga, Japan.
Takuya NikaidoDepartment of Orthopaedic Surgery, Fukushima Medical University School of Medicine, Fukushima, Japan.
Fukushima Medical University · JPSaga University · JPUniversity of the Ryukyus · JPKhon Kaen University · TH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite the recent advances in cancer treatment, the incidence of patients with spinal metastases continues to grow along with the total number of cancer patients. Spinal metastases can significantly impair activities of daily living (ADL) and quality of life (QOL), compared with other types of bone metastases, as they are characterized with severe pain and paralysis caused by skeletal-related events. Reduced ADL can also lead to treatment limitations as certain anticancer agents and radiation therapy are not compatible treatments; thus, leading to a shorter life expectancy. Consequently, maintaining ADLs in patients with spinal metastases is paramount, and spine surgeons have an integral role to play in this regard. However, neurosurgeon, orthopedic and spinal surgeons in Japan do not have a proactive treatment approach to spinal metastases, which may prevent them from providing appropriate treatment when needed (clinical inertia). To overcome such endemic inertia, it is essential for 1) spine surgeons to understand and be more actively involved with patients with musculoskeletal disorders (cancer locomo) and cancer patients; 2) the adoption of a multidisciplinary approach (coordination and meetings not only with the attending oncologist but also with spine surgeons, radiologists, rehabilitation specialists, and other professionals) to preemptive treatment such as medication, radiotherapy, and surgical treatment; and 3) the integration of the latest findings associated with minimally invasive spinal treatments that have expanded the indications for treatment of spinal metastases and improved treatment outcomes. This heralds a new era in the management of spinal metastases.

Indexed as

cancer locomominimally invasive spine surgerymultidisciplinary approachpreemptive treatmentspinal metastasis

Identifiers

PMID38694784
PMCPMC11062132
OpenAlexW4394853201

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.